These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24735152)

  • 1. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection?
    Hadziyannis SJ; Laras A; Hadziyannis E
    Aliment Pharmacol Ther; 2014 May; 39(10):1250-1. PubMed ID: 24735152
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply.
    Galmozzi E; Viganò M; Lampertico P
    Aliment Pharmacol Ther; 2014 May; 39(10):1251-2. PubMed ID: 24735153
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?
    Galmozzi E; Viganò M; Lampertico P
    Aliment Pharmacol Ther; 2014 Mar; 39(6):569-78. PubMed ID: 24461198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon therapy of hepatitis B and C].
    Jákó J
    Orv Hetil; 1995 Mar; 136(11):633. PubMed ID: 7535412
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of interferon therapy in patients with chronic hepatitis].
    Papa MZ; Halperin Z; Bar Meir S
    Harefuah; 1981 Jul; 101(1-2):27-8. PubMed ID: 6172325
    [No Abstract]   [Full Text] [Related]  

  • 6. Infection fighters. Interferon and ribavirin for hepatitis B.
    TreatmentUpdate; 2001; 12(9):2-3. PubMed ID: 12132444
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B and interferon].
    Oda T; Suzuki H; Mitamura K
    Nihon Rinsho; 1978 May; Suppl():2166-7. PubMed ID: 691678
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon for chronic hepatitis B.
    Koretz RL
    Ann Intern Med; 1996 Jan; 124(2):276-7. PubMed ID: 8534014
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon for chronic hepatitis B.
    Evans AA; London WT
    Ann Intern Med; 1996 Jan; 124(2):276; author reply 277. PubMed ID: 8534013
    [No Abstract]   [Full Text] [Related]  

  • 11. [The combination administration of interferon in viral hepatitis].
    Zhao GD; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytokines and hepatitis].
    Degos F
    Rev Prat; 1993 Mar; 43(5):569-73. PubMed ID: 7688135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C.
    Keshvari M; Pouryasin A; Behnava B; Sharafi H; Hajarizadeh B; Alavian SM
    Aliment Pharmacol Ther; 2014 Feb; 39(3):343. PubMed ID: 24397325
    [No Abstract]   [Full Text] [Related]  

  • 14. Administration of human fibroblast interferon in chronic hepatitis-B infection.
    Desmyter J; De Groote J; Desmet VJ; Billiau A; Ray MB; Bradburne AF; Edy VG; De Somer P
    Lancet; 1976 Sep; 2(7987):645-7. PubMed ID: 60513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of interferon in the treatment of viral hepatitis and its perspective].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokines in the pathogenesis and treatment of infectious diseases.
    Lau AS
    Adv Pediatr Infect Dis; 1994; 9():211-36. PubMed ID: 7510110
    [No Abstract]   [Full Text] [Related]  

  • 17. [IL28B genetic variation and hepatic ISGs expression predict treatment efficacy of IFN-based anti-viral therapy for chronic hepatitis C].
    Honda M; Kaneko S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():178-83. PubMed ID: 26845926
    [No Abstract]   [Full Text] [Related]  

  • 18. [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].
    Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Pálinkás L; Berki T; Vincze A; Kisfali P; Melegh B
    Orv Hetil; 2013 Aug; 154(32):1261-8. PubMed ID: 23916907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C--authors' reply.
    Stättermayer AF; Ferenci P
    Aliment Pharmacol Ther; 2014 Feb; 39(3):344. PubMed ID: 24397327
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon and prospects for treatment of viral hepatitis with same].
    Winogrodzka-Szaflik H
    Pol Tyg Lek; 1980 Mar; 35(10):365-7. PubMed ID: 6154289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.